Interactions of Shiga-like toxin with human peripheral blood monocytes
Tóm tắt
The cytotoxic effect of Shiga-like toxin (Stx; produced by certain Escherichia coli strains) plays a central role in typical hemolytic uremic syndrome (HUS). It damages the renal endothelium by inhibiting the cellular protein synthesis. Also, the monocyte has a specific receptor for Stx but is not sensitive for the cytotoxic effect. In this work, monocytes were studied as a potential transporter for Stx to the renal endothelium. Coincubation of isolated human monocytes loaded with Stx and target cells (vero cells and human umbilical vascular endothelial cells) were performed. Transfer was determined by measuring the protein synthesis of target cells and by flow cytometry. Furthermore, the effect of a temperature shift on loaded monocytes was investigated. Stx-loaded monocytes reduced the protein synthesis of target cells. After adding an antibody against Stx, incomplete recovery occurred. Also, adding only the supernatant of coincubation was followed by protein synthesis inhibition. Stx detached from its receptor on the monocyte after a change in temperature, and no release was detected without this temperature shift. Although the monocyte plays an important role in the pathogenesis of HUS, it has no role in the transfer of Stx.
Tài liệu tham khảo
Tarr P, Gordon C, Chandler W (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086
Besbas N, Karpman D, Landau D, Loirat C, Proesman W, Remuzzi G, Rizzoni G, Taylor M, van de Kar N, Zimmerhackl L (2006) A classification of haemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423–431
Heuvelink A, van de Kar N, Meis J, Monnens L, Melchers W (1995) Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with hemolytic-uremic syndrome in Western Europa. Epidemiol Infect 115:1–14
Karch H, Tarr P, Bielazewska M (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295:405–418
Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965–1975
Creydt V, Silberstein C, Zotta E, Ibarra C (2006) Cytotoxic effect of Shiga toxin-2 holotoxin and its B-subunit on human renal tubular epithelial cells. Microbes Infect 8:410–419
Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara Y, Igarashi K (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. Eur J Biochem 15:45–50
Chaisri U, Nagata M, Kurazono H, Horie H, Tongtawe P, Hayashi H, Watanabe T, Tapchaisri P, Chonqsa-nquan M, Chaicumpa W (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic syndrome. Microb Pathog 31:59–67
Paton J, Paton A (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479
Colpoys W, Cochran B, Carducci T, Thorpe C (2005) Shiga toxins activate translational regulation pathways in intestinal epithelial cells. Cell Signal 17:891–899
Miyamoto Y, Limura M, Kaper J, Torres A, Kagnoff M (2006) Role of shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol 8:869–879
Acheson D, Moore R, de Breucker S, Lincicome L, Jacewisz M, Skutelsky E, Keusch G (1996) Translocation of Shiga-toxin across polarized intestinal cells in culture. Infect Immun 64:3294–3300
Lingwood C (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4:147–153
Bitzan M, Richardson S, Huang, Boyd B, Petric M, Karmali M (1994) Evidence that verotoxins (Shiga-like toxin) from Escherichia coli bind to blood group antigens of human erythrocytes in vitro. Infect Immun 62:3337–3347
Cohen A, Madrid-Marina V, Estrov Z, Freedman M, Lingwood C, Dosch H (1998) Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteria disease. Int Immunol 2:11–18
Cooling L, Walker K, Gille T, Koerner T (1998) Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun 66:4355–4366
van Setten P, Monnens L, Verstraten R, van den Heuvel L, van Hinsbergh V (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174–183
Ramegowda B, Tesh V (1996) Differentiation-associated toxin receptor modulation, cytokine production and sensitivity to shiga-like toxins in human monocytes and monocytic cell lines. Infect Immun 64:1173–1180
Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453–2468
Harrison L, van Haaften W, Tesh V (2004) Regulation of proinflammatory cytokine expression by shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect Immun 72:2618–2627
Torgersen M, Lauvrak S, Sandvig K (2005) The A-subunit of surface-bound Shiga-toxin stimulates clathrin-dependent uptake of the toxin. FEBS J 272:4103–4113
Maciag T, Cerundolo J, Ilsley S, Kelley P, Forand R (1979) An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 73:5674–5678
Kimura T, Co M, Vasquez M, Wei S, Xu H, Tani S, Sakai Y, Kawamura T, Matsumoto Y, Nakao H, Takeda T (2002) Development of humanized monoclonal antibody TMA-15 which neutralizes shiga toxin 2. Hybrid Hybridomics 21:161–168
Jaffe E, Nachmann K, Becker C, Minick C (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2757–2764
Kim J, Lingwood C, Williams D, Furaya W, Manolson M, Grinstein S (1996) Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J Cell Biol 134:1387–1399
Campbell E, Silverman E, Campbell M (1989) Elastase and cathepsin G of human monocytes. J Immunol 143:2961–2968
Fernandez G, Ramos M, Gomez S, Dran G, Exeni R, Alduncin M, Grimoldi I, Vallejo G, Elias-Costa C, Isturiz M, Palermo M (2005) Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol 78:853–861
Kimura T, Tani S, Matsumoto Y, Takeda T (2001) Serum amyloid P component is the shiga toxin 2-neutralizing factor in human blood. J Biol Chem 276:41576–41579
Armstrong G, Mulvey G, Marcato P, Marcato P, Griener T, Kahan M, Tennent G, Sabin C, Chart H, Pepys M (2006) Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome. J Infect Dis 193:1120–1124